QualityStocksNewsBreaks Archives - Page 992 of 1614

WednesdayDec 30, 2020 12:31 pm

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Announces Strategic Acquisition Plans, Targets 500% Topline Growth

ISW Holdings (OTC: ISWH), a global brand management holdings company, today announced that it is closing in on key developments and announcements for its Telehealth and Home Health Care division, including one or more key acquisitions. Per the update, management believes these strategic moves have the potential to drive revenues as much as 500% higher on a year-over-year basis in 2021 (from a base exceeding $1 million in 2020). “We are closing in on key acquisitions that we believe could significantly increase the scale of our telehealth operations and materially ramp the company’s topline performance in 2021,” said Alonzo Pierce,…

WednesdayDec 30, 2020 12:06 pm

QualityStocksNewsBreaks – Net Element (NASDAQ: NETE) Announces Mullen Technologies Receives LOI for Purchase of 1,500 MX-05 EVs

Net Element (NASDAQ: NETE) is a financial technology company in the process of transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through a pending merger with privately held Mullen Technologies Inc. Mullen recently executed a nonbinding Letter of Intent (“LOI”) with Unlimited Electrical Contractors Corp (“UEC”), a premiere electrical contractor based in Pompano Beach, Florida. The LOI outlines agreements for the purchase of up to 10,000 of Mullen’s MX-05 electric vehicles (“EVs”), with an initial purchase order of 1,500 MX-05s, valued at an estimated $75 million. The LOI states that UEC may order an additional 8,500 vehicles by…

WednesdayDec 30, 2020 11:33 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) Adjourns Annual General Meeting

Siyata Mobile (NASDAQ: SYTA, SYTAW), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, announces that it has adjourned its annual general shareholder meeting; the meeting has been adjourned until Feb. 23, 2021. The meeting, which convened in Vancouver, British Columbia, on Dec. 29, 2020, was adjourned because new quorum requirements for the meeting were not met. Prior to that date, company shareholders will receive further details regarding the submission of proxies for the adjourned meeting. Proxies that had been received up before the proxy cut-off time for initial meeting were overwhelmingly in favor of…

WednesdayDec 30, 2020 11:26 am

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Announces $7.77M Private Placement

Creatd (NASDAQ: CRTD), the parent company of Vocal, today announced its entry into definitive securities purchase agreements in connection with a private placement of its Series E Convertible Preferred Stock (the "Preferred Stock") and warrants to existing shareholders as well as new institutional investors. Upon the closing of the financing, expected to occur on or prior to Jan. 4, 2021, Creatd expects to receive approximately $7.77 million in gross proceeds, not including any proceeds that may be received upon exercise of the warrants. The company intends to use the net proceeds of the financing to satisfy Nasdaq's stockholders' equity listing…

WednesdayDec 30, 2020 11:08 am

QualityStocksNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Publication Detailing Its Investigational Neuropharmaceuticals for Anxiety and Depression Disorders

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced that VistaGen Vice President, Translational Medicine Dr. Louis Monti and VistaGen CNS Clinical and Regulatory Advisory Board Member Dr. Michael Liebowitz authored an article published in CNS Spectrums, a Cambridge University Press journal. The article covers the proposed mechanism of action of VistaGen’s investigational neuroactive nasal sprays, PH94B and PH10, currently in development as potential rapid-onset treatments for anxiety and depression disorders.* The publication details the proposed neural circuits mediating the mechanism of action of pherines, including PH94B…

WednesdayDec 30, 2020 11:03 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Appoints Amp Energy Founder and CEO to PowerTap Hydrogen Fueling Corp. Advisory Board

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has announced the appointment of Amp Energy (“Amp”) founder and CEO Dave Rogers to the advisory board of PowerTap Hydrogen Fueling Corp. Before founding Amp, Rogers was the head of carbon markets at Front Street Capital, a $3.5-billion investment manager. In that capacity, he oversaw the origination, sale and trading of carbon credits globally. Rogers believes that hydrogen will play a critical role in the future as the world moves away from fossil-based generation and transportation, and that the proprietary PowerTap technology provides critical advantages over the rest…

WednesdayDec 30, 2020 10:51 am

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Commences FDA EUA Study for POC COVID-19 Testing

LexaGene Holdings (TSXV: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that it has started a series of studies required by the FDA for Emergency Use Authorization (“EUA”) testing for its COVID-19 assay in a point-of-care (“POC”) environment using its fully automated MiQLab(TM) system. “I’m excited we have progressed to the point where we have started our FDA study. Our open-access technology is unlike any other on the market today, as it could be configured quickly to detect new variants, such as the recent UK variant 1 (aka SARS-CoV-2 VUI 202012/01),”…

WednesdayDec 30, 2020 10:32 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Commences Study to Further Knowledge in Psilocybin, Associated Delivery Mechanisms

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushrooms sector, today announced that it is commencing a study on the formulation and manufacturing of psilocybin-based active treatments for oral tablets, capsules and a nasal gel that will be used as an investigational product. According to the update, the study with be conducted at the Toronto Institute of Pharmaceutical Technology (“TIPT”) by Dr. Alexander MacGregor, a key scientific advisor to Pure Extracts. The study will focus on formulating, manufacturing and clinical bioavailability testing of rapid onset psilocybin dosage forms…

WednesdayDec 30, 2020 10:25 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Q1 Results for Clarmin Explorations

Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, on Tuesday announced the unaudited financial results of Clarmin Explorations Inc. (now Cybin Inc.) for the three month period ended Oct. 31, 2020. According to the update, a copy of the consolidated financial statements prepared in accordance with International Financial Reporting Standards, as well as the corresponding management’s discussion and analysis for the three months ended Oct. 31, 2020, can be found under Cybin’s profile at www.SEDAR.com. To view the full press release, visit https://ibn.fm/Qiu7X About Cybin Inc. Cybin is a life sciences company advancing psychedelic pharmaceutical treatments…

WednesdayDec 30, 2020 9:58 am

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) Cancels Upcoming Special Meeting of Stockholders

Predictive Oncology’s (NASDAQ: POAI) Board of Directors has announced that it will cancel the Special Meeting of Stockholders that was scheduled for today. Originally scheduled for Dec. 1, 2020, the meeting was adjourned on that date and rescheduled for Dec. 30 because a quorum had not been reached. As of the rescheduled date, the required quorum had still not been reached, with only 47% of the outstanding shares having been voted. In cancelling the meeting, the Board of Directors for POAI, a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, noted that it was…

Site Search

Company Search

Category: QualityStocksNewsBreaks